Literature DB >> 30982128

A potential role for the gut microbiome in substance use disorders.

Katherine R Meckel1,2, Drew D Kiraly3,4,5.   

Abstract

Pathological substance use disorders represent a major public health crisis with limited effective treatment options. While much work has been done to understand the neuronal signaling networks and intracellular signaling cascades associated with prolonged drug use, these studies have yielded few successful treatment options for substance use disorders. In recent years, there has been a growing interest to explore interactions between the peripheral immune system, the gut microbiome, and the CNS. In this review, we will present a summary of existing evidence, suggesting a potential role for gut dysbiosis in the pathogenesis of substance use disorders. Clinical evidence of gut dysbiosis in human subjects with substance use disorder and preclinical evidence of gut dysbiosis in animal models of drug addiction are discussed in detail. Additionally, we examine how changes in the gut microbiome and its metabolites may not only be a consequence of substance use disorders but may in fact play a role in mediating behavioral response to drugs of abuse. While much work still needs to be done, understanding the interplay of gut microbiome in substance use disorders may offer a promising avenue for future therapeutic development.

Entities:  

Keywords:  Addiction; Alcohol; Cocaine; Dysbiosis; Gut-brain; Metabolites; Microbiome; Microbiota; Opioid

Mesh:

Substances:

Year:  2019        PMID: 30982128      PMCID: PMC6599482          DOI: 10.1007/s00213-019-05232-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  143 in total

Review 1.  Liver-Microbiome Axis in Health and Disease.

Authors:  Timon E Adolph; Christoph Grander; Alexander R Moschen; Herbert Tilg
Journal:  Trends Immunol       Date:  2018-05-26       Impact factor: 16.687

Review 2.  Gut microbiota and gastrointestinal health: current concepts and future directions.

Authors:  Q Aziz; J Doré; A Emmanuel; F Guarner; E M M Quigley
Journal:  Neurogastroenterol Motil       Date:  2013-01       Impact factor: 3.598

Review 3.  Microglia: scapegoat, saboteur, or something else?

Authors:  Adriano Aguzzi; Ben A Barres; Mariko L Bennett
Journal:  Science       Date:  2013-01-11       Impact factor: 47.728

4.  Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration.

Authors:  Trissa Babrowski; Christopher Holbrook; Jonathan Moss; Lawrence Gottlieb; Vesta Valuckaite; Alexander Zaborin; Valeriy Poroyko; Donald C Liu; Olga Zaborina; John C Alverdy
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

Review 5.  Bacterial translocation: overview of mechanisms and clinical impact.

Authors:  Silvio Balzan; Claudio de Almeida Quadros; Roberto de Cleva; Bruno Zilberstein; Ivan Cecconello
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

6.  Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.

Authors:  C Acharya; N S Betrapally; P M Gillevet; R K Sterling; H Akbarali; M B White; D Ganapathy; A Fagan; M Sikaroodi; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2016-11-20       Impact factor: 8.171

Review 7.  Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.

Authors:  Allison Agus; Julien Planchais; Harry Sokol
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

Review 8.  Epigenetic signaling in psychiatric disorders: stress and depression.

Authors:  Rosemary C Bagot; Benoit Labonté; Catherine J Peña; Eric J Nestler
Journal:  Dialogues Clin Neurosci       Date:  2014-09       Impact factor: 5.986

9.  Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.

Authors:  Shashi Bala; Miguel Marcos; Arijeet Gattu; Donna Catalano; Gyongyi Szabo
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

10.  Epigenetic regulation of brain region-specific microglia clearance activity.

Authors:  Pinar Ayata; Ana Badimon; Hayley J Strasburger; Mary Kaye Duff; Sarah E Montgomery; Yong-Hwee E Loh; Anja Ebert; Anna A Pimenova; Brianna R Ramirez; Andrew T Chan; Josefa M Sullivan; Immanuel Purushothaman; Joseph R Scarpa; Alison M Goate; Meinrad Busslinger; Li Shen; Bojan Losic; Anne Schaefer
Journal:  Nat Neurosci       Date:  2018-07-23       Impact factor: 24.884

View more
  34 in total

Review 1.  A biological framework for emotional dysregulation in alcohol misuse: from gut to brain.

Authors:  Carina Carbia; Séverine Lannoy; Pierre Maurage; Eduardo López-Caneda; Kenneth J O'Riordan; Timothy G Dinan; John F Cryan
Journal:  Mol Psychiatry       Date:  2020-12-07       Impact factor: 15.992

2.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 3.  Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.

Authors:  Richa Jalodia; Yaa Fosuah Abu; Mark Ryan Oppenheimer; Bridget Herlihy; Jingjing Meng; Irina Chupikova; Junyi Tao; Nillu Ghosh; Rajib Kumar Dutta; Udhghatri Kolli; Yan Yan; Eridania Valdes; Madhulika Sharma; Umakant Sharma; Shamsudheen Moidunny; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-07       Impact factor: 4.147

4.  Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats.

Authors:  Bethany Crouse; Li Zhang; Christine Robinson; Yuguang Ban; Jennifer R Vigliaturo; Sabita Roy; Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2021-08-19       Impact factor: 4.526

5.  Methamphetamine exposure and its cessation alter gut microbiota and induce depressive-like behavioral effects on rats.

Authors:  Shadab Forouzan; Kristi L Hoffman; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2020-10-23       Impact factor: 4.530

Review 6.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

Review 7.  Potential gut-brain mechanisms behind adverse mental health outcomes of bariatric surgery.

Authors:  Robyn M Brown; Eva Guerrero-Hreins; Wendy A Brown; Carel W le Roux; Priya Sumithran
Journal:  Nat Rev Endocrinol       Date:  2021-07-14       Impact factor: 43.330

8.  Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine.

Authors:  Rebecca S Hofford; Nicholas L Mervosh; Tanner J Euston; Katherine R Meckel; Amon T Orr; Drew D Kiraly
Journal:  Neuropsychopharmacology       Date:  2021-06-14       Impact factor: 7.853

Review 9.  Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis.

Authors:  Enrico Patrono; Jan Svoboda; Aleš Stuchlík
Journal:  Behav Brain Funct       Date:  2021-06-22       Impact factor: 3.759

Review 10.  Decoding the Role of Gut-Microbiome in the Food Addiction Paradigm.

Authors:  Marta G Novelle
Journal:  Int J Environ Res Public Health       Date:  2021-06-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.